{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:52:21Z","timestamp":1787014341566,"version":"build-2736575974"},"reference-count":27,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2014,12,30]],"date-time":"2014-12-30T00:00:00Z","timestamp":1419897600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["PG\/08\/083\/25779"],"award-info":[{"award-number":["PG\/08\/083\/25779"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000664","name":"NIHR Health Technology Assessment programme","doi-asserted-by":"crossref","award":["10\/104\/24"],"award-info":[{"award-number":["10\/104\/24"]}],"id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Stroke"],"published-print":{"date-parts":[[2015,4]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Antiplatelet agents such as aspirin, clopidogrel and dipyridamole are effective in reducing the risk of recurrence after a stroke. Importantly, the risk of recurrence is highest immediately after the index event while antiplatelets cause bleeding.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims and\/or hypothesis<\/jats:title>\n                    <jats:p>The \u2018Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke\u2019 (TARDIS) trial is testing whether short-term intensive antiplatelet therapy is safe and effective in reducing the early risk of recurrence as compared with standard guideline-based therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>TARDIS is an international multicenter prospective randomized open-label blinded-end-point trial, with funding from the UK Health Technology Assessment program. Patients with acute ischemic stroke or transient ischemic attack are randomized within 48 h to intensive\/triple antiplatelet therapy or guideline antiplatelets taken for one-month. Patients or relatives give written informed (proxy) consent and all sites have research ethics approval. Analyses will be done by intention-to-treat.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study Outcome<\/jats:title>\n                    <jats:p>The primary outcome is shift in stroke recurrent events and their severity, assessed using the modified Rankin Scale, at three-months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This paper and attachment describe the trial's statistical analysis plan, as developed from the protocol during recruitment and prior to unblinding of data. The statistical analysis plan contains design and methods for analyses, and unpopulated tables and figures for the primary and baseline publications. The data from the trial will provide the first large-scale randomized evidence for the use of intensive anti-platelet therapy for preventing recurrence after acute stroke and transient ischemic attack.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/ijs.12445","type":"journal-article","created":{"date-parts":[[2014,12,30]],"date-time":"2014-12-30T05:24:38Z","timestamp":1419917078000},"page":"449-451","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":20,"title":["Statistical Analysis Plan for the \u2018Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke\u2019 (TARDIS) Trial"],"prefix":"10.1177","volume":"10","author":[{"given":"Philip M. W.","family":"Bath","sequence":"first","affiliation":[{"name":"Stroke Trials Unit, Division of Clinical Neuroscience, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Robson","sequence":"additional","affiliation":[{"name":"Stroke Trials Unit, Division of Clinical Neuroscience, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa J.","family":"Woodhouse","sequence":"additional","affiliation":[{"name":"Stroke Trials Unit, Division of Clinical Neuroscience, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikola","family":"Sprigg","sequence":"additional","affiliation":[{"name":"Stroke Trials Unit, Division of Clinical Neuroscience, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Dineen","sequence":"additional","affiliation":[{"name":"Imaging Sciences, Division of Clinical Neuroscience, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Pocock","sequence":"additional","affiliation":[{"name":"Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2014,12,30]]},"reference":[{"key":"bibr1-ijs.12445","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61448-2"},{"key":"bibr2-ijs.12445","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(07)70248-X"},{"key":"bibr3-ijs.12445","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)04011-7"},{"key":"bibr4-ijs.12445","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)04010-5"},{"key":"bibr5-ijs.12445","volume":"43","author":"Geeganage CM","year":"2012","journal-title":"Dual or mono antiplatelet therapy for patients with acute ischemic stroke or transient ischemic attack stroke"},{"key":"bibr6-ijs.12445","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1215340"},{"key":"bibr7-ijs.12445","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.003187"},{"key":"bibr8-ijs.12445","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0704248"},{"key":"bibr9-ijs.12445","doi-asserted-by":"publisher","DOI":"10.1080\/0953710021000024367"},{"key":"bibr10-ijs.12445","doi-asserted-by":"publisher","DOI":"10.1185\/030079903125001721"},{"key":"bibr11-ijs.12445","doi-asserted-by":"publisher","DOI":"10.1160\/TH04-09-0559"},{"key":"bibr12-ijs.12445","doi-asserted-by":"publisher","DOI":"10.1080\/09537100500235966"},{"key":"bibr13-ijs.12445","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0002852"},{"key":"bibr14-ijs.12445","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2004.03.001"},{"key":"bibr15-ijs.12445","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)03651-5"},{"key":"bibr16-ijs.12445","doi-asserted-by":"publisher","DOI":"10.1111\/ijs.12235"},{"key":"bibr17-ijs.12445","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.107.509893"},{"key":"bibr18-ijs.12445","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.108.527044"},{"key":"bibr19-ijs.12445","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.106.474080"},{"key":"bibr20-ijs.12445","doi-asserted-by":"publisher","DOI":"10.1111\/j.1747-4949.2008.00184.x"},{"key":"bibr21-ijs.12445","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.108.519207"},{"key":"bibr22-ijs.12445","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1366"},{"key":"bibr23-ijs.12445","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.111.641456"},{"key":"bibr24-ijs.12445","volume-title":"Clopidogrel and modifiedrelease dipyridamole in the prevention of occlusive vascular events","author":"(NICE) NIfHaCE","year":"2005"},{"key":"bibr25-ijs.12445","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.106.473579"},{"key":"bibr26-ijs.12445","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-12-101"},{"key":"bibr27-ijs.12445","doi-asserted-by":"publisher","DOI":"10.1111\/j.1747-4949.2007.00092.x"}],"container-title":["International Journal of Stroke"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fijs.12445","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1111\/ijs.12445","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1111\/ijs.12445","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1111\/ijs.12445","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:32:26Z","timestamp":1741653146000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1111\/ijs.12445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,30]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["10.1111\/ijs.12445"],"URL":"https:\/\/doi.org\/10.1111\/ijs.12445","relation":{},"ISSN":["1747-4930","1747-4949"],"issn-type":[{"value":"1747-4930","type":"print"},{"value":"1747-4949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,30]]}}}